Evidence map›Paper›PMID 31831559›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Harmonic Motion Imaging of Pancreatic Tumor Stiffness Indicates Disease State and Treatment Response.

Thomas Payen, Paul E Oberstein, Niloufar Saharkhiz, Carmine F Palermo, Stephen A Sastra, Yang Han, Alireza Nabavizadeh, Irina R Sagalovskiy, Barbara Orelli, Vilma Rosario and 8 more

Open access · greenAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Optimization of the Tracking Beam Sequence in Harmonic Motion Imaging.IEEE transactions on ultrasonics, ferroelectrics, and frequency control · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Extracellular matrix physical properties govern the diffusion of nanoparticles in tumor microenvironment.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. FUS-Net: U-Net-Based FUS Interference Filtering.IEEE transactions on medical imaging · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Thomas PayenDepartment of Biomedical Engineering, Columbia University Irving Medical Center, New York, New York.
Paul E Oberstein *Division of Oncology, Department of Medicine, New York University Langone Medical Center, New York, New York.ORCID 0000-0001-5918-6004
Niloufar Saharkhiz *Department of Biomedical Engineering, Columbia University Irving Medical Center, New York, New York.ORCID 0000-0002-1656-6282
Carmine F PalermoHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
Stephen A SastraHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
Yang HanDepartment of Biomedical Engineering, Columbia University Irving Medical Center, New York, New York.ORCID 0000-0002-8843-6970
Alireza NabavizadehDepartment of Biomedical Engineering, Columbia University Irving Medical Center, New York, New York.
Irina R SagalovskiyHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
Barbara OrelliHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
Vilma RosarioDivision of GI/Endocrine Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, New York.
Deborah DesrouilleresDepartment of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, New York.
Helen RemottiDepartment of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, New York.ORCID 0000-0003-1555-9299
Michael D KlugerHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
Beth A SchropeHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.ORCID 0000-0003-0313-8120
John A ChabotHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
Alina C IugaDepartment of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, New York.
Elisa E KonofagouDepartment of Biomedical Engineering, Columbia University Irving Medical Center, New York, New York. ek2191@columbia.edu kenolive@columbia.edu.ORCID 0000-0002-9636-7936
Kenneth P OliveHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York. ek2191@columbia.edu kenolive@columbia.edu.
Columbia University Irving Medical Center · USNYU Langone Health · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Clinical and Translational Science AwardKL2TR000081 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$3.3M
An integrated theranostic system for breast cancerR01CA228275 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KONOFAGOU, ELISA E. · 2018 to 2022
$2.7M
NCATS NIH HHS KL2 TR000081NCI NIH HHS P30 CA013696NCI NIH HHS R01 CA228275
6 · The paper itself

Abstract

purposePancreatic ductal adenocarcinoma (PDA) is a common, deadly cancer that is challenging both to diagnose and to manage. Its hallmark is an expansive, desmoplastic stroma characterized by high mechanical stiffness. In this study, we sought to leverage this feature of PDA for two purposes: differential diagnosis and monitoring of response to treatment. EXPERIMENTAL

designHarmonic motion imaging (HMI) is a functional ultrasound technique that yields a quantitative relative measurement of stiffness suitable for comparisons between individuals and over time. We used HMI to quantify pancreatic stiffness in mouse models of pancreatitis and PDA as well as in a series of freshly resected human pancreatic cancer specimens.

resultsIn mice, we learned that stiffness increased during progression from preneoplasia to adenocarcinoma and also effectively distinguished PDA from several forms of pancreatitis. In human specimens, the distinction of tumors versus adjacent pancreatitis or normal pancreas tissue was even more stark. Moreover, in both mice and humans, stiffness increased in proportion to tumor size, indicating that tuning of mechanical stiffness is an ongoing process during tumor progression. Finally, using a brca2-mutant mouse model of PDA that is sensitive to cisplatin, we found that tissue stiffness decreases when tumors respond successfully to chemotherapy. Consistent with this observation, we found that tumor tissues from patients who had undergone neoadjuvant therapy were less stiff than those of untreated patients.

conclusionsThese findings support further development of HMI for clinical applications in disease staging and treatment response assessment in PDA.

Indexed as

Phantoms, ImagingAgedAged, 80 and overAnimalsDiagnosis, DifferentialDisease Models, AnimalElasticity Imaging TechniquesFemaleHumansMaleMiceMice, Inbred BALB CMice, TransgenicMiddle AgedMotionNeoplasm Staging

Identifiers

PMID31831559
PMCPMC7073277
OpenAlexW2995945891

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.